Yuqi Hu

student at HKU

[Rainee Yang @RaineeYang_HKU]

Our latest study has been published in
@AnnalsofIM. The DOAC group had a higher 1-year risk of stroke than warfarin in Asian AF-MS patients. We also found that rivaroxaban increased the risk of stroke, while non-rivaroxaban DOACs did not.
Full paper: https://t.co/6Nq1kxVJMj

[Xinya Mu @Silvia1536629]

Happy to share my first PhD paper in Pharmacological Research 🎉

Using a Japanese claims database, we found that concomitant use of quetiapine and Bupleuri Radix (Chaihu)-containing formulations was associated with increased risk of acute adverse events.

https://t.co/qy8Stf8HLa

[Eric YF Wan @EricWan_HKU]

Our paper in Diabetes Research and Clinical Practice suggests optimising #lipid monitoring frequency by baseline #LDL‑C levels for primary prevention of #cardiovascular disease #CVD in patients with type 2 #diabetes #T2DM.

https://t.co/DVBfdYd0at

[Eric YF Wan @EricWan_HKU]

In our #multinational study in @JInternMed, #statin initiation may be associated with increased risk of incident #MyastheniaGravis #MG during the first 6–12 months, with a greater magnitude of risk elevation for higher intensity of statin therapy.
https://t.co/V0t7QlR9a7

[Yin Zhang @zhangyin0904]

Happy to share our study on global Clostridioides difficile infection treatment trends in International Journal of Antimicrobial Agents. Use of fidaxomicin and oral vancomycin is rising globally, but access remains unequal across regions and incomes.
🔗 https://t.co/eKc7XdUTTq

[Prof Ian Wong @Prof_IanWong]

Major milestone of HK Pharmacy Profession

Primary Healthcare Commission announces Community Drug Formulary mechanism and Guidelines of Practice for Community Pharmacy to pave way for launch of Community Pharmacy Programme next year (with photo) https://t.co/mvTakTYu5H

[Edmund Cheung @edmundccheung]

Our multinational database study in @eClinicalMed
compared antihypertensive prescribing trends in Hong Kong, United Kingdom, Sweden, and Australia, providing evidence on the use of blood pressure-lowering drugs before and after a diagnosis of dementia.
https://t.co/CDKZL0dcQq

[Franco WT Cheng @kfranco_c]

Our new meta-analysis in Hypertension Research confirms Sacubitril/Valsartan effectively reduces both office and out-of-office blood pressure.

This was a fantastic international collaboration with our colleagues at Chulalongkorn University.

https://t.co/gzOjOurHA4

[Prof Ian Wong @Prof_IanWong]

Antiseizure medications consumption in 73 countries and regions from 2... https://t.co/HNXH8GE6d2
Our Aston U, HKU, UCL, WHO study shows that inequities in access to newer antiseizure drugs in developing countries where valproate used a lot. Good risk management is needed

[Callie Caige Huang @Callie_Huang123]

Excited to share our latest study in @LancetRH_WPac : Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic, with variations in consumption patterns observed across different countries. @Esther_CSMPRHKU
https://t.co/umLRvID1Tl

[Luna Wei Yue @WeiYLuna]

Excited to share our latest study in @TheLancet: long-acting injectable antipsychotics (LAIAs) are more effective than oral and equally safe for older people, except for higher risk of EPS with typical LAIAs, but not with atypical LAIAs. @Esther_CSMPRHKU
https://t.co/xQB0YitlVz

[Eric YF Wan @EricWan_HKU]

Our @CMAJ study found a less stringent #risk threshold of 30% for intensifying #PrimaryCare encounters frequency is associated with increased overall #CVD risks and all-cause #mortality of aged 60+ #T2DM patients, but not for those below 60.
https://t.co/zNwz2HTKNd

[Min Fan @fm_fanmin]

Our modified self-controlled case series (https://t.co/ovfmS22Lul) did not identify an increased #ischemic_stroke risk with #PPI_monotherapy. However, co-prescription with #antithrombotics was associated with a higher risk. Careful monitoring is needed for them.
@ChuiCeline

[Eric YF Wan @EricWan_HKU]

Our age-specific models accurately predicted the post-acute #mortality risk within 1 year of #COVID infection, optimizing clinical strategies and resource allocation in global burden of #LongCOVID management. Published on @_qjm_.
https://t.co/KypBNSfUyJ

[Shirley Xue Li @snowly12191]

Our simulation model supports the cost-effectiveness of PSA screening in China. Personalised screening based on genetic risk may provide an efficient alternative to uniform strategies by reducing unnecessary interventions for lower risk individual.https://t.co/RmgT9apD7k

[Eric YF Wan @EricWan_HKU]

Our @JACCJournals paper found that #statin use for primary #prevention was associated in all-cause #mortality and major #CVD reductions with a very low risk of adverse effects among #T1DM adults, guiding personalized statin #treatment decisions in T1DM.
https://t.co/oRKFeT0DvQ

[Prof Ian Wong @Prof_IanWong]

"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read https://t.co/rPoLEEMVtr

[Celine Chui HKU @ChuiCeline]

Duramax, a reinforcement learning framework designed to optimize long-term lipid-modifying therapy for CVD prevention. It helps bridge the gap between AI-driven precision and real-world clinical utility.

https://t.co/oLYZVsrj3a

[Eric YF Wan @EricWan_HKU]

Our #EJPC paper found that the Risk Assessment and Management Programme for #Hypertension (RAMP-HT) supplementing usual care associated with reduced relative risk of #CVD and all-cause #mortality in HT patients compared to those receiving usual care only.
https://t.co/YZzJhhYpsk

[Yuqi Hu @YuqiHu_]

Thrilled to share our study in The Lancet Psychiatry @TheLancet ! Deep gratitude to Dr. Lai @FranciscoTTLai1 for his guidance in this research and my PhD process. Using Hong Kong data, we reveal new evidence on clozapine use and infections. 💊